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Background Recent tobacco smoking has been identified as a risk factor for
developing tuberculosis, and two studies which have investigated
its association with relapse of tuberculosis after completion of
treatment had conflicting results (and did not control for confound-
ing). The objective of this study was to investigate risk factors for
tuberculosis relapse, with emphasis on smoking.
Methods A cohort of newly diagnosed TB cases was followed up from their
discharge after completion of treatment (in 2001–2003) until
October 2006 and relapses of tuberculosis ascertained during that
period. A case of relapse was defined as a patient who started
a second treatment during the follow up.
Results Smoking (OR 2.53, 95% CI 1.23–5.21) and living in an area where
the family health program was not implemented (OR 3.61, 95% CI
1.46–8.93) were found to be independently associated with relapse
of tuberculosis.
Conclusions Our results establish that smoking is associated with relapse of
tuberculosis even after adjustment for the socioeconomic variables.
Smoking cessation support should be incorporated in the strategies
to improve effectiveness of Tuberculosis Control Programs.
Keywords Tuberculosis control, successful treatment, relapse, risk factors,
smoking
Introduction
Tuberculosis is a significant health problem worldwide;
control of tuberculosis relies heavily on identification
and successful treatment of cases. Treatment schedules
last for 6 months. One of the problems of tuberculosis
control is the fact that cases that were successfully
treated can relapse, needing a second treatment. Iden-
tification of factors that increase the risk of relapse
of tuberculosis after cure or completion of treatment is
of great interest. The monitoring of the effectiveness of
tuberculosis programs is based on the routine classifi-
cation of the outcome of each tuberculosis treatment
into: (i) treatment failure (patient still have positive
smear 5 months after start of treatment or later);
(ii) death (patient who dies for any reason during
the course of treatment); (iii) default (patient inter-
rupts treatment for two consecutive months or more);
(iii) cure (patient who is sputum smear negative in two
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841consecutive tests, at least one in the last months of
treatment); (iv) treatment completed (a patient who
has completed treatment, has no symptoms, but does
not meet the criteria for cure because of the absence
of a sputum test in the last month of treatment,
usually because a sputum test was not conducted or
the patient could not produce sputum). Patients clas-
sified as cure or completed treatment are considered
treatment successes.
1
In Recife, Brazil, where this study is conducted, 16% of
the people starting treatment against tuberculosis had
had at least one previous treatment. Of this, one-third
had cured or completed treatment and therefore was a
relapse.
2 This is typical of many developing countries.
So far, factors known to increase the risk of relapse are
restricted to deficiencies in treatment (taking the drugs
irregularly, taking the wrong drugs, taking the right
drugs in the wrong dosage); and (probably as indicators
of deficiencies in treatment) patients missing consulta-
tions, having adverse events to the drugs used in the
treatment of tuberculosis and health services problems
like irregular supply of drugs.
3 Most exciting, and of
potential relevant to relapse, recently tobacco smok-
ing has been identified as a risk factor for develop-
ing tuberculosis. The proposed biological mechanism
for this is a decreased resistance to Mycobacterium
tuberculosis due to functional and morphological changes
to macrophages in the alveoli of smokers.
4,5 It is
therefore plausible that smoking may increase the
risk of relapse, by increasing risk of persistence of
M. tuberculosis infection after treatment and risk of any
residual M. tuberculosis infection leading to disease.
5
Two studies have investigated this possibility and had
conflicting results.
3,6 None controlled for confounding.
This article reports on a study of risk factors for
relapse, based on the analysis of cases of relapse in a
cohort of cases of tuberculosis that was followed up
from start of tuberculosis treatment to expected date
for completion of treatment, for a previous study, and
then followed up for this analysis for 3–5 years after
completion of treatment.
Methods
Study population and design
Site of the study was Recife, a city with a population
of one and half million people in the northeast of
Brazil. In 2002, the incidence of tuberculosis in Recife
was 104 per 100000 inhabitants
7 and treatment
consisted of an initial phase of isoniazid, rifampicin
and pyrazinamide lasting for 2 months, followed by
a second phase with isoniazid and rifampicin only
for a period of 4 months.
8 This is different from the
internationally recommended first-line treatment
which uses four drugs in the initial phase, 2 months
of ethambutol associated to isoniazid, rifampicin and
pyrazinamide.
9 The objective of the analysis reported
here was to identify risk factors for tuberculosis
relapse leading to re-treatment in those who com-
pleted their tuberculosis treatment successfully and
survived the follow-up period. Methods of the main
study (following cases from diagnosis to completion
of treatment) were described elsewhere but in short
cases of tuberculosis diagnosed from May 2001 to
July 2003 who were residents in Recife and aged
13 years or older were recruited into the study,
completed a questionnaire on potential risk factors
and had blood collected for anti-HIV serology. Imme-
diate outcome of treatment was ascertained from the
register of the health unit where each patient was
treated and from each patient’s medical record, soon
after the expected date of end of treatment and again
6 months later, and classified into failure, default,
death, confirmed cure or completion of treatment.
Results of the initial study of determinants of the
outcome of tuberculosis treatment were published
elsewhere.
10,11 In October 2006, additional informa-
tion was sought to identify cases from the cohort who
relapsed (started re-treatment for tuberculosis after
successful completion of treatment); information on
patients who died was sought for exclusion from the
cohort and for sensitivity analysis.
The study population in this analysis consisted of
patients from the original cohort who were discharged
from the first treatment after treatment success.
1 Exclu-
sion criteria were: not having completed treatment, fail-
ure of treatment/having a positive smear at the end
of treatment (as these would remain in treatment
with a different scheme); having died and having had
a previous treatment for tuberculosis (as these were
already relapses when recruited into the first study,
of determinants of outcome of treatment).
We did not examine separately those with negative
sputum at the end of treatment and those with no
sputum (cures vs competed treatment) as numbers
were not large enough for subgroup analysis; we did
not expect the two groups to be different because
the main reason for not having a sputum test late in
the course of treatment was that the test was not
requested (data not shown). A case of relapse was
defined as a patient, from the original cohort dis-
charged because of cure or completion of treatment,
who was diagnosed with tuberculosis and started
a second course of treatment during the follow up
period. Patients from the original cohort who survived
to the end of the follow up period and did not start
a new treatment were the comparison group.
We identified relapses by searching the Surveillance
System for Infectious Diseases (SINAN/MS). SINAN/
MS is an electronic system with notifications of infec-
tious diseases managed by the Ministry of Health
(MS) in Brazil. The search was done using name and
date of birth. In Brazil, tuberculosis treatment is
carried out only by the public sector and to receive
tuberculosis treatment a patient must be notified,
so the notification system should include all diag-
nosed cases receiving treatment. We identified deaths
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the routine mortality system (SIM/MS), an electronic
system with all routine mortality data with cause
of death coded to ICD managed by the Ministry of
Health in Brazil. SIM/MS was searched based on
name and date of birth; and the cause of death was
abstracted for all deaths linked to the cohort.
Exposure information had been collected as part of
the previous study (follow up from first diagnosis of
tuberculosis to discharge) from a standard pre-coded
questionnaire in an interview conducted face to face
by a trained interviewer and information abstracted
from the tuberculosis treatment record and included:
(i) Clinical and epidemiological factors: treatment delay
(defined as delay between onset of symptoms
and start of treatment (the cut-off point adopted
was according to Santos et al.
10); Clinical form of
tuberculosis (pulmonary or extra pulmonary)
and HIV co-infection; history of contact with other
cases of tuberculosis: knowing somebody with TB;
and living in the same house as a TB patient.
(ii) Biological factors: age and sex.
(iii) Social factors: employment status of patient and of
the head of the household; literacy; income and
schooling of the head of the household; access to
water supply; ownership of goods (radio, refrig-
erator, video, washing machine, microwave
oven, computer, TV set, air conditioning and a
car); number of goods (the number of goods was
grouped as follows: first, possession of each of
the different goods was counted as 1, indepen-
dent of the number of each good possessed (for
example, owning two cars counted as owning
one good); then, the number of goods possessed
was summed and grouped into four categories:
0–1; 2–3; 4–6 and 7 or more goods.
(iv) Lifestyle: Alcohol consumption, grouped as: does
not drink, drinks rarely, drinks at least once a
week, drinks every day and once starts drinking
finds it difficult to stop. They were aggregated
during analysis in two groups: light drinker
(none, drinking rarely, weekly) and heavy
drinker (drinking every day or finding it difficult
to stop once start drinking). Smoking, grouped
into whether the person was a smoker at the
time of the interview (smokers), had never
smoked (never smokers), or used to smoke but
stopped, and the date when stopped (ex smok-
ers). For the analysis, because of small numbers
and because the hypothesis was that the effect
of smoking disappears with time, those who
never smoked were grouped with those that had
given up smoking one year or more before the
interview).
(v) Access to health services: number of health units
attended with the complaint eventually diag-
nosed as tuberculosis before it was diagnosed
and treatment started, whether unit attended
was in the same neighborhood and in the
district of residence of case and whether the
Family Health Program (FHP) was implemented
in the Health District of residence of case at the
time of the start of the treatment. The FHP is a
new program in which a team of trained health
visitors visit families in the community. Each
team is responsible for approximately 3200 resi-
dents in a defined geographical area and is
linked to a FHP team of clinicians and other
health professionals in a supporting health unit.
The FHP was being implemented during the
study period and some but not all of the study
areas were covered.
Statistical analysis
Logistic regression was used to identify risk factors
for relapse. Time since end of treatment and ascer-
tainment of re-treatment in October 2006 varied,
a variable indicating the year of the end of the first
treatment was included in all models. Variables asso-
ciated with the outcome with a P-value 40.25 or with
an odds ratio of 51.5 were included in a multiple
logistic regression analysis which also included the
year of entry in the cohort. A step-up procedure was
used. Crude and adjusted ORs and 95% CIs were
calculated. Since smoking is associated with poverty
and alcohol consumption, to increase the confidence
that the association between re-treatment and smok-
ing was not a result of confounding by socioeconomic
status, additional unplanned analysis were under-
taken exploring the effect of each of a large number
of social variables collected as part of the first study
on the relationship between smoking and relapse:
employment status of patient and of the head of the
household; literacy; income and schooling of the head
of the household; access to water supply; ownership
of each of the following goods—radio, refrigerator,
video, washing machine, microwave oven, computer,
television set, air conditioning, car; number of goods
owned; and alcohol consumption. To explore the
potential consequences of excluding deaths a sensi-
tivity analysis was conducted modelling the conse-
quences of treating as relapses (i) all deaths coded to
tuberculosis and (ii) all deaths. Data were stored by a
software program (EPI-INFO version 6.04; Centers for
Disease Control, Atlanta, GA) and analysed using
STATA 9.0 (Stata-Corp LP, College Station, TX). The
study was approved by the Ethical Committee of the
Center of Health Sciences of the Federal University
of Pernambuco. All patients signed an informed
consent form.
Results
A total of 1353 diagnosed TB patients had been iden-
tified for potential selection from the previous study
from May 2001 to July 2003. Of these, 311 patients
were not eligible for the first study because they
SMOKING AND TUBERCULOSIS RELAPSE 843referred previous treatment for tuberculosis (and so
were already relapses) and 42 patients because they
were under 13 years of age. Thus, 1000 patients of
potential interest for this analysis were followed
during the period of the tuberculosis treatment.
From this group, 246 patients were not eligible for
this analysis because they had an unsuccessful out-
come (146 defaulters, 25 died during the course of
treatment, 16 were treatment failures), 28 were
excluded because they transferred out to a different
tuberculosis treatment unit and 31 because they had
no information on outcome of treatment. The study
population therefore consisted of 754 patients with
successful treatment outcomes (cured or completed
treatment), and they were followed until 31 October
2006. During the follow-up period, 43 patients were
excluded because they died after completion of
treatment; therefore the final group consisted of 711
patients, of which 37 relapsed and 674 had not
relapsed by the end of follow up (Figure 1).
The mean age of cases in the analysis was 38.7 in
males and 35.6 in females. In this study the rate of
relapse was 5% (37/711 patients). Approximately half
(48.7%) of the cases of relapse occurred in the first
year after discharge.
Tables 1–4 show the results of univariable analysis
of the association between relapse and risk factors,
adjusted by the year of entry in the cohort. Among
biological and lifestyle factors (Table 1), only smok-
ing was associated with relapse (OR 2.34, 95% CI
1.17–4.68). None of the socioeconomic factors was
associated with relapse (Table 2). Among the vari-
ables related to health services, only not living in an
area that receives visits by the FHP was associated
Figure 1 Study flow diagram
Table 1 Association between relapse of tuberculosis and biologic and lifestyle characteristics of individuals, OR—crude
and adjusted by the year of entry in the cohort, Recife 2006
Biological factors
and lifestyle
Relapse Control
N % N % Crude OR (CI) P OR (CI) Adjusted P
Age (years) 0.154 0.401
13–29 10 4.13 232 95.87 1.00 – 1.00 –
30–49 22 6.96 294 93.04 1.73 (0.81–3.74) 0.159 1.72 (0.80–3.72) 0.164
550 5 3.27 148 96.73 0.78 (0.26–2.34) 0.662 0.79 (0.26–2.35) 0.668
Total 37 – 674 –
Sex
Female 14 5.56 238 94.44 1.00 – 1.00 –
Male 23 5.01 436 94.99 0.89 (0.45–1.77) 0.755 0.88 (0.44–1.76) 0.732
Total 37 – 674 –
Alcohol consumption
None or light drinker 32 5.32 569 94.68 1.00 – 1.00 –
Heavy drinker 3 4.05 71 95.95 0.75 (0.22–2.52) 0.643 0.76 (0.22–2.54) 0.653
Total 35 – 640 –
Cigarette smoking
Never smoking or given
up smoking
23 4.16 530 95.84 1.00 – 1.00 –
Ever smoking 14 9.21 138 90.79 2.33 (1.17–4.66) 0.016 2.34 (1.17–4.68) 0.016
Total 37 – 668 –
844 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYTable 2 Association between relapse of tuberculosis and socioeconomic characteristics of individuals, OR—crude
and adjusted by the year of entry in the cohort, Recife 2006
Social factors
Relapse Control
N % N % Crude OR (CI) P OR (CI) Adjusted P
Literacy
Yes 33 5.37 582 94.63 1.00 – 1.00 –
No 4 4.17 92 95.83 0.76 (0.26–2.21) 0.624 0.75 (0.25–2.17) 0.596
Total 37 – 674 –
Employment
Yes 12 5.45 208 94.55 1.00 – 1.00 –
No 25 5.11 464 94.89 0.93 (0.46–1.89) 0.850 0.93 (0.45–1.89) 0.844
Total 37 – 672 –
Number of individuals per household
1–4 24 5.90 383 94.10 1.00 – 1.00 –
55 13 4.44 280 95.56 0.74 (0.37–1.48) 0.396 0.73 (0.37–1.47) 0.391
Total 37 – 663 –
Income of head of household (MW)
52 5 3.60 134 96.40 1.00 – 1.00 –
<2 31 6.14 474 93.86 1.75 (0.67–4.59) 0.254 1.75 (0.67–4.61) 0.253
Total 36 – 608 –
Employment of head of household
Yes 19 5.21 346 94.79 1.00 – 1.00 –
No 18 5.20 328 94.80 0.99 (0.51–1.93) 0.998 0.99 (0.51–1.92) 0.986
Total 37 – 674 –
Schooling of the head of household
9 or more years 3 2.78 105 97.22 1.00 – 1.00 –
Up to 8 years 31 5.58 525 94.42 2.06 (0.62–6.88) 0.237 2.06 (0.61–6.89) 0.239
Total 34 – 630 –
Piped water
Yes 35 5.29 627 94.71 1.00 – 1.00 –
No 2 4.44 43 95.56 0.83 (0.19–3.58) 0.806 0.85 (0.20–3.69) 0.835
Total 37 – 670 –
Ownership of washing machine
Yes 7 4.86 137 95.14 1.00 – 1.00 –
No 29 5.17 532 94.83 1.06 (0.45–2.48) 0.881 1.06 (0.45–2.47) 0.890
Total 36 – 669 –
Ownership of microwave oven
Yes 3 3.95 73 96.05 1.00 – 1.00 –
No 33 5.29 591 94.71 1.36 (0.41–4.54) 0.619 1.35 (0.40–4.53) 0.627
Total 36 – 664 –
Ownership of computer
Yes 2 3.03 64 96.97 1.00 – 1.00 –
No 35 5.52 599 94.48 1.87 (0.44–7.95) 0.397 1.86 (0.43–7.94) 0.399
Total 37 – 663 –
(continued)
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Social factors
Relapse Control
N % N % Crude OR (CI) P OR (CI) Adjusted P
Ownership of a car
Yes 8 5.88 128 94.12 1.00 – 1.00 –
No 29 5.07 543 94.93 0.85 (0.38–1.91) 0.702 0.84 (0.37–1.89) 0.685
Total 37 – 671 –
Ownership of air conditioning
Yes 2 2.44 80 97.56 1.00 – 1.00 –
No 35 5.58 592 94.42 2.36 (0.56–10.0) 0.243 2.32 (0.54–9.85) 0.255
Total 37 – 672 –
Number of goods possessed 0.312 0.592
7–9 goods 3 4.69 61 – 1.00 – 1.00
4–6 goods 8 3.77 204 0.744 0.80 (0.20–3.10) 0.750 0.80 (0.20–3.12) 0.750
2–3 goods 19 5.23 344 0.855 1.12 (0.32–3.91) 0.858 1.12 (0.32–3.92) 0.858
0–1 goods 6 10.53 51 0.234 2.39 (0.57–10.04) 0.243 2.36 (0.56–9.97) 0.243
Total 36 – 660 –
Table 3 Association between relapse of tuberculosis and health services variables, OR—crude and adjusted by the
year of entry in the cohort, Recife 2006
Access to health
services factors
Relapse Control
N % N % Crude OR (CI) P OR (CI) Adjusted P
Number of health units
Only 1 5 3.73 129 96.27 1.00 – 1.00 –
52 31 5.50 533 94.50 1.50 (0.57–3.93) 0.409 1.47 (0.56–3.88) 0.428
Total 36 – 662 –
HS in same district of residence
Yes 23 5.18 421 94.82 1.00 – 1.00 –
No 14 5.24 253 94.76 1.01 (0.51–2.00) 0.971 1.02 (0.52–2.04) 0.935
Total 37 – 674 –
HS in neighborhood of residence
Yes 7 7.78 83 92.22 1.00 – 1.00 –
No 30 4.83 591 95.17 0.60 (0.25–1.41) 0.244 0.60 (0.25–1.41) 0.244
Total 37 – 674 –
Residence in areas of FHP visits
Yes 6 2.32 253 97.68 1.00 – 1.00 –
No 30 6.99 399 93.01 3.17 (1.30–7.72) 0.011 3.25 (1.33–7.94) 0.010
Total 36 – 652 –
Health District of treatment 0.412 0,615
HD IV 6 3.51 165 96.49 1.00 – 1.00 –
HD I 0 0 59 100.0 – – – –
HD II 7 4.55 147 95.45 1.31 (0.43–3.98) 0.635 1.35 (0.42–4.29) 0.609
HD III 11 8.21 123 91.79 2.46 (0.88–6.83) 0.084 2.43 (0.87–6.82) 0.091
HD V 11 6.81 149 93.13 2.03 (0.73–5.62) 0.173 2.08 (0.74–5.77) 0.160
HD VI 2 6.06 31 93.94 1.77 (0.34–9.19) 0.495 1.86 (0.35–9.79) 0.461
Total 37 – 674 –
846 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYwith relapse (OR 3.25, 95% CI 1.33–7.94) (Table 3).
The only clinical or epidemiological factor associated
with relapse was having had a delay of 60 or more
days before start of the first treatment of tuberculosis
and even this was borderline (OR 2.23, 95% CI
0.99–4.98) (Table 4).
Table 5 shows the results of the multivariable
analysis. The following variable remained in the
final model: smoking (OR 2.53; 95% CI 1.23–5.21)
and living in an area in which the FHP was not
implemented (OR 3.61; 95% CI 1.46–8.93).
The association between relapse and smoking was
adjusted for all socioeconomic variables and alcohol
consumption to exclude the possibility of confounding
by these variables. There was no important change in
the magnitude of this association when these
Table 4 Association between relapse of tuberculosis and clinical and epidemiological characteristics of individuals,
OR—crude and adjusted by the year of entry in the cohort, Recife 2006
Clinical and
epidemiological factors
Relapse Control
N % N % Crude OR (CI) P OR (CI) Adjusted P
Knows someone with tuberculosis
No 23 5.64 385 94.36 1.00 – 1.00 –
Yes 14 4.75 281 95.25 0.83 (0.42–1.64) 0.602 0.83 (0.42–1.65) 0.606
Total 37 – 666 –
Household contact with a case of tuberculosis
No 32 5.22 581 94.78 1.00 – 1.00 –
Yes 05 5.10 93 94.90 0.97 (0.37–2.57) 0.961 0.98 (0.37–2.59) 0.974
Total 37 – 674 –
Clinical form of tuberculosis
Pulmonary 31 5.12 574 94.88 1.00 – 1.00 –
Extra pulmonary 05 4.81 99 95.19 0.93 (0.35–2.46) 0.892 0.93 (0.35–2.45) 0.889
Total 36 – 673 –
Treatment delay
460 days 8 3.01 258 96.99 1.00 – 1.00 –
460 days 28 6.57 398 93.43 2.27 (1.01–5.05) 0.045 2.23 (0.99–4.98) 0.050
Total 36 – 656 –
HIV co-infection 0.962 0.972
No 1 7.14 13 92.86 1.00 – 1.00 –
Yes 12 5.38 211 94.62 0.74 (0.09–6.13) 0.780 0.76 (0.09–6.40) 0.807
Not known 24 5.37 423 94.63 0.73 (0.09–5.87) 0.774 0.76 (0.09–6.15) 0.804
Total 37 – 647 –
Table 5 Multivariate analysis of the association between relapse of tuberculosis and characteristics of individuals,
OR—crude and adjusted for each other and by the year of entry in the cohort, Recife 2006
OR and 95% CI,
adjusted by
year of entry in
the cohort P
OR and 95% CI,
adjusted by
year of entry in
the cohort, and
by each other P paf
Cigarette smoking
Never smoking or given up smoking 1.00 – 1.00 –
Ever smoking 2.34 (1.17–4.68) 0.016 2.53 (1.23–5.21) 0.011 0.228
Residence in areas of FHP visits
Yes 1.00 – 1.00 –
No 3.25 (1.33–7.94) 0.010 3.61 (1.46–8.93) 0.005 0.585
SMOKING AND TUBERCULOSIS RELAPSE 847variables were included in the model; the change in
the value of the crude and adjusted OR was less
than 10%; when adjustment was made for income,
the CI was wider and close to 1 but this was
associated with a small change in the value of the
OR (from 2.33 to 2.03). To evaluate the potential
effect of misclassification of relapse in patients who
died we repeated the analysis considering the six
deaths with tuberculosis as the cause and considering
all 43 deaths as relapses. The inclusion of these cases
did not affect substantially our results, as only minor
changes of the ORs were observed: The OR was 2.05
(95% CI 1.06–3.96) when six deaths were treated as
relapses and 1.97 (95% CI 1.19–3.25) when all deaths
were treated as relapses.
Discussion
Smoking and living in an area where the FHP was not
implemented were found to be independently asso-
ciated with relapse of tuberculosis.
The incidence of relapse in this cohort of patients
(5.2%) was lower than that found by Thomas et al.
in a study carried out in South India (12.3%).
6 This
difference might be related to some extent to differ-
ences between the two populations (for example in
degree of under nutrition), but we believe that the
two most likely explanations are active ascertainment
in the Indian study and better treatment adherence in
Brazil. We expand on these below. First, in the Indian
case study finding was active with field workers
visiting the study subjects at 6, 12 and 18 months
after completion of treatment, and will have identified
cases that might have progressed to cure without
diagnosis, and cases that would have been diagnosed
much later, whereas in the Brazilian study relapses
were ascertained as they presented to health services
with symptoms. Second, the quality of the tubercu-
losis control program in Brazil is probably better than
in India. The quality of the programme is essential
in assuring adherence to treatment, and low adher-
ence is a well-established determinant of relapse. The
tuberculosis control programme has been improving
in Brazil, with a marked decrease in the percentage of
patients notified with relapse in the city of Recife as
well as in Brazil, from 2001 to 2005.
7
In our study the bulk (64.8%) of the relapses occur-
red during the first year of follow-up. This finding is
similar to that of Nogueira et al. and Oliveira and
Moreira who found, respectively, percentages of 65%
and 61.9% year after completion of treatment.
12,13
In this study, as expected, neither sex nor age nor
social factors were risk factors for relapse of tuber-
culosis. Similar results were found by Oliveira and
Moreira, and Ormerod and Prescott.
3,14
Tuberculosis has been characterized as a disease
of poverty, but this is an aspect of developing tuber-
culosis, not of relapse. Measures of low socioeconomic
status, like low family income, illiteracy and low social
class have been found to be associated with an
increased risk of developing tuberculosis.
15 Although
socioeconomic variables have never been shown to
be associated with an increase in tuberculosis relapse,
inadequate treatment has, and it is possible that
poverty may lead to inadequate treatment in some
circumstances. Even in countries where the tubercu-
losis control program is well structured and diag-
nosis and treatment are provided with no costs to the
patient, cases may not be able to pay the indirect costs
of treatment, e.g. for transport to the health units.
16
In a study carried out in Salvador, Northeast of Brazil,
the costs to families because of loss of income and
expenses due to the disease were very high, on average
33% of the family income.
17 In Recife, where this study
was conducted, low socioeconomic status, measured
as illiteracy or low income of the head of household
increased the risk of all three negative outcomes of
tuberculosis treatment—dropout, treatment failure
and death.
11 However, the present study in the same
population found no association of relapse to poverty.
This may be because of low power, or may indicate the
relative magnitude of biological mechanisms on
relapse.
The present study found no association between
alcohol consumption and relapse, which differs from
the study of Selassie et al. which described an increase
of almost 4-fold in the risk of relapse in the group
of alcoholics.
18 However, Selassie et al. did not control
for smoking, and if alcohol and tobacco consumption
are associated in that setting, the association measured
may be reflecting an unmeasured effect of smoking.
In relation to the role of alcohol consumption and
smoking in the risk of developing tuberculosis (rather
than relapsing), Ruffino-Neto and Ruffino,
19 several
decades ago, investigated the synergism between these
two factors and found that smoking was associ-
ated with tuberculosis only in the group of drinkers
(alcohol), whereas Brown and Campbell, on examin-
ing confounding between the two variables, concluded
that alcohol had a stronger association with tuber-
culosis.
20 Due to these findings, smoking was adjusted
for alcohol consumption in the present study, but there
was no confounding effect between alcohol consump-
tion and smoking on the risk of relapse (data not
shown). In addition, as smoking is more frequent
among the poor, the association between smoking and
relapse was adjusted for each of the socioeconomic
variables collected previously and there was only a very
small change in the value of the OR. Thomas et al., who
also described an association between smoking and
relapse, did not control for the socioeconomic factors.
6
Despite the fact that in the second half of the last
century several studies pointed to an association
between smoking and developing tuberculosis,
19,21,22
there was a gap of decades until scientific interest in
this topic was renewed. More recently, studies have
investigated and found evidence of smoking as a risk
factor for developing tuberculosis, independently,
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of progression from latent tuberculosis infection to
disease.
4,5 The association between smoking and
death from tuberculosis remains controversial; while
in the review of Chiang et al. smoking was associated
with increased TB mortality,
23 Bates et al. described
no clear effect of smoking on the case fatality rate in
those with active TB.
24
Smoking was found to be significantly associated
with relapse in the present study (OR 2.34; 95% CI
1.17–4.68) corroborating the finding of Thomas et al.
who described a similar association (OR 3.1, 95% CI
1.6–6.0).
6 Several studies highlight the association
between smoking and the development of tuber-
culosis
4,5,23–25 and the mechanism proposed to
explain this association is the neutralisation of the
tumour necrosis factor a (TNF-a) in the pulmonary
macrophages by substances of the tobacco, leaving
the patient more susceptible to a progressive devel-
opment of disease from latent tuberculosis infec-
tion.
5 The reduction in the TNF-a in this group
may be explained by the high level of iron in the
bronchoalveolar macrophages of smokers.
26 This
mechanism may also be behind the development of
relapse.
Tobacco consumption has been increasing mainly in
developing countries. In Brazil, one of the greatest
producers and exporters of tobacco, the National
Program of Control of Smoking, of the Ministry of
Health, has been acting through the National Institute
of Cancer (INCA), and there has been some important
achievements as a decrease of nearly 50% in the
prevalence of smokers between 1989 and 2003.
27
Nevertheless, it is still important to incorporate in the
strategies of the Tuberculosis Control Program the
evidence that smoking increases the risk of relapse.
This knowledge may become one more tool in the
control of the disease.
Concerning the factors related to health services, the
risk of relapse was significantly lower among patients
living in areas where the FHP was implemented. The
Ministry of Health has defined a policy of decentra-
lization and has transferred to the local authorities
the administration of the health services. This policy
which aims to facilitate the access to health services
and includes periodical visits of trained and reason-
ably well-paid health agents to all families has been
implemented with good results.
28 The Tuberculosis
Control Plan emphasizes the performance of the
health agents and FHP teams as a tool to increase
the therapeutic adherence and prevent patients from
interrupting treatment.
8,29 During the period from
2000 and 2006, the proportion of health services that
implemented supervised treatment, whether or not
using the FHP, increased from 7 to 81%.
30 In Recife,
as in Brazil as a whole, there has been a marked
decrease in the percentage of patients notified with
relapse from 2001 to 2005.
7 It was not possible to
establish the degree of adherence in this study, as
there is no record of treatment adherence. However, a
robust explanation for the lower rate of relapse in
patients who received visits from the agent from the
FHP is that the visits lead to better adherence to
treatment during the 6 months long therapeutic
regimen. A closer monitoring of tuberculosis patients
even after discharge would have increased detection
of relapsed patients and tend to decrease the
magnitude of the association.
Since Brazil does not follow the internationally
recommended first-line treatment,
9 it is of course not
possible to evaluate if the type of treatment affects
the frequency of relapse in this study, although the
proportion of cases relapsing is not out of line with
other countries. Concerning the association between
FHP and smoking with relapse, as all patients studied
were treated with the same drug regimen, this would
not distort the association between these factors and
relapse, but of course to generalize these findings to
other treatment regimens the study must be repeated
in the appropriate settings.
A limitation of this study was that we did not use
the CAGE standard questionnaire to ascertain alco-
holism, and therefore can only speak of alcohol
consumption. Another limitation is that it is not
possible to differentiate relapse due to reactivation of
the disease from tuberculosis resulting form a new
infection, as genotyping was not used to identify the
strains of M. tuberculosis. This is not unusual: Cox
et al.
31 reported that only one, among the 16 studies
included in their systematic review, differentiated true
relapse from reinfection with a different strain of
M. tuberculosis.
Ascertainment of outcomes relied on a routine
surveillance system and studies relying on passive
detection of relapse are more likely to under-report.
However, we expect that in Brazil, the risk relapse
without diagnoses is low because the National
Program for Tuberculosis Control (PNCT) has stan-
dard procedures for investigation and diagnosis in the
whole country and the standardized treatment regi-
men is only delivered after the case is notified to
SINAN. The potential risk of differential detection of
relapse for different groups, e.g. by SES, is minimized
by the partnership of the PNCT with the Community
Outreach Program (PACS) and FHP which widens the
actions and coverage of the PNCT, especially in areas
of low SES.
28,29
A total of 43 patients were excluded because they
died after completion of the successful treatment, and
this could generate survival bias. Tuberculosis was
pointed as basic cause of death in 6 of the 43 (data
from mortality information system of the Ministry of
Health—SIM/MS). However, sensitivity analysis con-
firmed that the results are not affected by including
deaths coded to tuberculosis and other deaths,
suggesting that any survival bias must be very small.
It is possible that other factors might be associated
with relapse, including short temporary interruptions
SMOKING AND TUBERCULOSIS RELAPSE 849of treatment, diabetes and malnutrition. Information
on these were not collected. They may have a
significant impact on risk of relapse but we have no
reason to think that they would be associated with
smoking.
The sample size- the small number of relapses—may
be a limitation of this study. Some associations, espe-
cially those related to socioeconomic conditions and
alcohol consumption may have been present and not
have been identified because of the power of the
study. However, this does not question the validity of
the associations found.
Our findings are relevant for Tuberculosis Control
Programs. Since just to cure patients may not be
enough to achieve the control of the disease (as cured
patients can relapse), it is important to incorporate in
the strategies of the Tuberculosis Control Program
strategies to reduce the risk of relapse, including
smoke cessation support. Finally, the effect of home
visits of the FHP confirms that in successful treat-
ments of tuberculosis, close monitoring of adherence
during the 6 months of the treatment may help
prevent relapses.
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